Rowland Carmichael Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$1.31M Sell
11,147
-93
-0.8% -$10.2K 0.41% 50
2020
Q3
$1.17M Buy
11,240
+1,530
+16% +$154K 0.46% 53
2020
Q2
$890K Buy
9,710
+2,486
+34% +$238K 0.38% 64
2020
Q1
$651K Sell
7,224
-982
-12% -$104K 0.33% 81
2019
Q4
$931K Buy
8,206
+57
+0.7% +$6.25K 0.32% 83
2019
Q3
$885K Sell
8,149
-909
-10% -$94.8K 0.3% 85
2019
Q2
$882K Sell
9,058
-84
-0.9% -$7.67K 0.31% 86
2019
Q1
$833K Sell
9,142
-217
-2% -$19.4K 0.31% 90
2018
Q4
$851K Sell
9,359
-2,530
-21% -$236K 0.38% 53
2018
Q3
$1.17M Buy
11,889
+1,471
+14% +$136K 0.45% 43
2018
Q2
$892K Sell
10,418
-481
-4% -$40.2K 0.38% 66
2018
Q1
$874K Buy
10,899
+1,039
+11% +$85.7K 0.48% 72
2017
Q4
$796K Sell
9,860
-129
-1% -$10.3K 0.41% 75
2017
Q3
$777K Buy
9,989
+10
+0.1% +$830 0.43% 69
2017
Q2
$886K Buy
9,979
+548
+6% +$46.2K 0.51% 60
2017
Q1
$760K Sell
9,431
-1,204
-11% -$94K 0.46% 69
2016
Q4
$758K Buy
10,635
+70
+0.7% +$5.5K 0.45% 75
2016
Q3
$913K Sell
10,565
-209
-2% -$18.2K 0.58% 62
2016
Q2
$935K Buy
10,774
+1,566
+17% +$127K 0.59% 58
2016
Q1
$691K Buy
+9,208
New +$694K 0.64% 55

Other funds holding MDT

Rowland Carmichael Advisors's MDT Position: Q4 2020 in Review

Rowland Carmichael Advisors reduced its Medtronic (MDT) stake by 0.83% in Q4 2020, selling an estimated $10.2K and leaving 11,147 shares worth $1.31M. The position accounts for 0.41% of the portfolio, ranked #50.

Rowland Carmichael Advisors first reported a position in MDT in Q1 2016 and has held it in 20 quarters since. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • Rowland Carmichael Advisors held 11,147 shares of Medtronic worth $1.31M as of Q4 2020.
  • Rowland Carmichael Advisors sold 93 Medtronic shares in Q4 2020, an estimated $10.2K.
  • Medtronic made up 0.41% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #50 holding.
  • Rowland Carmichael Advisors first reported a position in Medtronic in Q1 2016 and has held it in 20 quarters since.
  • 1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.